Griffithsin (GRFT) Fast-Dissolving Insert (FDI)
The Griffithsin (GRFT) fast-dissolving insert (FDI) is developed by Population Council. This fast-dissolving vaginal insert is an on-demand HIV prevention product for women and girls, including pregnant and breastfeeding women, designed for over-the-counter distribution as a non-antiretroviral option. Manufacturable in low- and middle-income countries, the safe, discreet, user-controlled, and portable fast-dissolving insert has activity against HIV, HSV-2, and HPV, and may be suitable for over-the-counter distribution. Building on favorable outcomes in animal models, the GRFT FDI will be advanced through pre-clinical studies, production of good manufacturing practice FDIs, and the conduct of Phase 1 trials.
Development Stage:
Pre-formulation
Hormonal/Non-Hormonal:
Non-Contraceptive
Delivery Route & Method:
Topical - Fast Dissolving Insert/Capsule-Vaginal
Developer:
- Population Council
Funding:
- U.S. Agency for International Development (USAID)
Active Ingredient(s):
- Unspecified
Product Indication(s):
- HIV
- HPV
- HSV-1
- HSV-2